Artificial Discs

Total disc replacement is a surgical option for treating degenerative disc disease in the cervical or lumbar spine while preserving spinal flexibility and mobility. More than 400 million people worldwide suffer from symptomatic degenerative disc disease. In 2022, global sales of artificial cervical and lumbar discs totaled nearly $400.0m. Key factors driving growth in this market include a desire for patients to avoid spinal fusion and maintain motion in the spine, an aging demographic, and growing clinical evidence supporting safety/efficacy. Limiters to market growth include reimbursement restrictions by public and private insurance, patient selection criteria, and the challenging surgical technique for lumbar procedures.

This new report from Meddevicetracker includes a discussion of products, current/forecast markets, competitors, and opportunities in the global market for artificial discs. This market is segmented by product type (including cervical disc replacements and lumbar disc replacements). Regions covered by this analysis include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of World. The forecast range for this report is 2022–27.

If you are not a subscriber to Meddevicetracker and would like to purchase this report, please send an email to [email protected]. If you would like more information about obtaining a subscription to the Meddevicetracker database and report library, please send an email to [email protected].

Related Medtech Insight articles:

• ZimVie Wins Investigational Device Exemption For Disc Replacement Device, Plans To Begin Study
• Globus Medical To Merge With NuVasive In $3.1Bn All-Stock Deal Analysts Foresee Challenges
• NuVasive Adds Artificial Cervical Disc By Acquiring Simplify For $150M
• Subscribe to Medtech Insight to view these articles and more!